EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
17 hedge funds and large institutions have $12.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
$1.58M |
2 |
GCL
Glazer Capital LLC
New York
|
$56K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
$1K |